Change in tau phosphorylation associated with neurodegeneration in the ME7 model of prion disease.
Asuni
Ayodeji A
AA
CNS Inflammation Group, University of Southampton, Southampton SO16 7PX, UK. asuni@mac.com
Perry
V Hugh
VH
O'Connor
Vincent
V
D000818:Animals; D004195:Disease Models, Animal; D038362:Glycogen Synthase Kinase 3 / Q000378:metabolism*; D006801:Humans; D051379:Mice; D009410:Nerve Degeneration / Q000378:metabolism*; D010766:Phosphorylation; D017096:Prion Diseases / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D011328:Prions / Q000009:adverse effects; D016875:tau Proteins / Q000737:chemistry / Q000378:metabolism* / Q000502:physiology
D011328:Prions; D016875:tau Proteins; D038362:Glycogen Synthase Kinase 3; C080888:tau-protein kinase